If you are not happy with the results below please do another search
…for use in Iron Deficiency/Anaemia, Gluten sensitivity and Celiac Disease. Read more www.nemysisltd.com Danilo Casadei -Massariโ Chairman of the Board โNemysis Ltd 7 D’Olier Street D02HF60 Dublin Ireland +35315313450 casadei-massari@nemysisltd.com…
…It is, therefore, suitable for the enzymatic management of gluten intolerance and sensitivity. www.nemysisltd.com Danilo Casadei-Massari Chairman of the Board Nemysis Ltd 7 D’Olier Street D02HF60 Dublin Ireland +35315313450 casadei-massari@nemysisltd.com…
…+353 1 5313450 For R&D enquiries, please contact Maria Christina Comelli our R&D Director at comelli@nemysisltd.com. Name* Email* Phone* Subject Message* Consent* I agree to the terms and conditions laid…
…casadei-massari@nemysisltd.com or Marco Cartolari, our COO at cartolari@nemysisltd.com. Partnering Nemysis Nemysis is built on success, with an enviable product and research pipeline. And we are growing fast. We believe we…
PRESS RELEASE • OCT 17, 2023 08:00 BST DUBLIN, October 17, 2023 (Newswire.com) – Nemysis is pleased to announce that the company was recently covered by a research note published…
…R&D, medical, pharmaceutical, and commercial know-how to bring products to market. We have a clear aspiration and commitment to utilise cutting edge science and technology to address unmet clinical needs….
…line with our commercial strategy”. Danilo Casadei-Massari, Nemysis’ Chairman and CEO, states: “This is an important step in the development of Nemysis, taking us from a pre-commercial, development-focused company to…
…revenues from IHAT confirming our evolution from an R&D-focused company to a commercial company. This partnership demonstrates great interest in the first product we have developed to market which, combined…
…revenues from IHAT confirming our evolution from an R&D-focused company to a commercial company. This partnership demonstrates great interest in the first product we have developed to market which, combined…
…ingestion of gluten and other components of wheat leads to a series of serious gastro-intestinal and other severe reactions. E40 is a new Glutenase, developed to specifically address these conditions….
Nutritional deficiency research for healthier living
Head Office
Suite 4.01 Ormond Building
31-36 Ormond Quay Upper
Arran Quay
Dublin 7
D07 F6DC
Ireland
ยฉ Nemysis Ltd 2024 | Web design by Genetic Digital Privacy Policy | Cookie Policy